Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections

Abstract

More local data on CA-MRSA infections are needed so that dermatologists and community physicians can assess the risk of such infections amongst their patients and avoid the inappropriate administration of beta-lactams. No simple change in prescribing practices will entirely alleviate selective pressure for the spread of community-acquired MRSA and not exacerbate resistance in pyogenic streptococci, commonly found together with S. aureus in skin and soft tissue infections. The importance of hygiene in preventing the spread of community-acquired MRSA in the community must be reemphasized.

Type IV SCCmec found in decade old Brazilian MRSA isolates

“…It is predominantly associated with skin and soft tissue infections (especially abscesses and cellulitis). When present, risk factors are generally similar to those for infection with MSSA [28]. Some CA-MRSA strains have entered the hospital environment and caused outbreaks of infection, which has led to difficulty in distinguishing these strains from traditional nosocomial ones.…”

Antibiotic Resistance in the Environment, with Particular Reference to MRSA

“…PVL has not yet been found in pig-associated strains (Huijsdens et al, 2006), but more studies need to be conducted to confirm this. There are relatively few CA-MRSA strains, with 6 currently recognised (Eady and Cove, 2003). It has been suggested that these strains are associated with particular niches (Shukla, 2005), concurring with the potential association of the above sequence types with pigs and pig farmers.…”

Diagnosis and Treatment of Diabetic Foot Infections

“…Al- Figure 1. Algorithm 1, part 1: approach to treating a diabetic patient with a foot wound though MRSA strains have previously been isolated mainly from hospitalized patients, community-associated cases are now becoming common [45] and are associated with worse outcomes in patients with diabetic foot infections [46][47][48]. Vancomycin (or glycopeptide)-intermediate S. aureus has been isolated in several countries.…”